VRDN
Viridian Therapeutics Inc.
$17.00
-$0.24(-1.39%)
36
Overall
60
Value
27
Tech
23
Quality
Market Cap
$1.59B
Volume
1.49M
52W Range
$13.18 - $34.29
Target Price
$33.88
EPS Estimates Overview
| Current Quarter | $-1 | Next Quarter | $-0.86 |
| Current Year | $-3.71 | Next Year | $-2.4 |
| QoQ Growth | +14.0% | YoY Growth | +35.3% |
| 3Y EPS CAGR | +6.4% | Target Price | $33.88 |
| Consensus | Buy | Upside | +99.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $17.00 | -1.4% | 1.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW